Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 10419560)

1.

Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms.

Pan YX, Xu J, Bolan E, Abbadie C, Chang A, Zuckerman A, Rossi G, Pasternak GW.

Mol Pharmacol. 1999 Aug;56(2):396-403.

2.

Differential expressions of the alternatively spliced variant mRNAs of the µ opioid receptor gene, OPRM1, in brain regions of four inbred mouse strains.

Xu J, Lu Z, Xu M, Rossi GC, Kest B, Waxman AR, Pasternak GW, Pan YX.

PLoS One. 2014 Oct 24;9(10):e111267. doi: 10.1371/journal.pone.0111267. eCollection 2014.

3.

Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals.

Dever SM, Costin BN, Xu R, El-Hage N, Balinang J, Samoshkin A, O'Brien MA, McRae M, Diatchenko L, Knapp PE, Hauser KF.

AIDS. 2014 Jan 2;28(1):19-30. doi: 10.1097/QAD.0000000000000113.

4.

Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P.

Xu J, Xu M, Bolan E, Gilbert AK, Pasternak GW, Pan YX.

Synapse. 2014 Apr;68(4):144-52. doi: 10.1002/syn.21727. Epub 2014 Jan 16.

5.

Morphine regulates expression of μ-opioid receptor MOR-1A, an intron-retention carboxyl terminal splice variant of the μ-opioid receptor (OPRM1) gene via miR-103/miR-107.

Lu Z, Xu J, Xu M, Pasternak GW, Pan YX.

Mol Pharmacol. 2014 Feb;85(2):368-80. doi: 10.1124/mol.113.089292. Epub 2013 Dec 3.

6.

Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.

Xu J, Xu M, Brown T, Rossi GC, Hurd YL, Inturrisi CE, Pasternak GW, Pan YX.

J Biol Chem. 2013 Jul 19;288(29):21211-27. doi: 10.1074/jbc.M113.458687. Epub 2013 Jun 11.

7.

Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated μ opioid receptor (MOR-1) splice variants.

Majumdar S, Subrath J, Le Rouzic V, Polikar L, Burgman M, Nagakura K, Ocampo J, Haselton N, Pasternak AR, Grinnell S, Pan YX, Pasternak GW.

J Med Chem. 2012 Jul 26;55(14):6352-62. doi: 10.1021/jm300305c. Epub 2012 Jul 16.

8.

Differential expression and HIV-1 regulation of μ-opioid receptor splice variants across human central nervous system cell types.

Dever SM, Xu R, Fitting S, Knapp PE, Hauser KF.

J Neurovirol. 2012 Jun;18(3):181-90. doi: 10.1007/s13365-012-0096-z. Epub 2012 Apr 20.

9.

Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.

Majumdar S, Grinnell S, Le Rouzic V, Burgman M, Polikar L, Ansonoff M, Pintar J, Pan YX, Pasternak GW.

Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19778-83. doi: 10.1073/pnas.1115231108. Epub 2011 Nov 21.

10.

Evidence that "brain-specific" FOX-1, FOX-2, and nPTB alternatively spliced isoforms are produced in the lens.

Bitel CL, Nathan R, Wong P, Kuppasani S, Matsushita M, Kanazawa H, Frederikse PH.

Curr Eye Res. 2011 Apr;36(4):321-7.

PMID:
21714144
11.

Mu opioid receptors in pain management.

Pasternak G, Pan YX.

Acta Anaesthesiol Taiwan. 2011 Mar;49(1):21-5. doi: 10.1016/j.aat.2010.12.008. Epub 2011 Mar 17. Review.

12.

Identification and characterization of seven new exon 11-associated splice variants of the rat μ opioid receptor gene, OPRM1.

Xu J, Xu M, Rossi GC, Pasternak GW, Pan YX.

Mol Pain. 2011 Jan 21;7:9. doi: 10.1186/1744-8069-7-9.

13.

Involvement of mouse μ-opioid receptor splice variants in the spinal antinociception induced by the dermorphin tetrapeptide analog amidino-TAPA.

Mizoguchi H, Watanabe C, Higashiya T, Takeda S, Moriyama K, Yonezawa A, Sato T, Komatsu T, Sakurada T, Sakurada S.

Eur J Pharmacol. 2011 Jan 25;651(1-3):66-72. doi: 10.1016/j.ejphar.2010.10.049. Epub 2010 Oct 31.

PMID:
21047509
14.

Molecular assays for characterization of alternatively spliced isoforms of the u opioid receptor (MOR).

Gris P, Cheng P, Pierson J, Maixner W, Diatchenko L.

Methods Mol Biol. 2010;617:421-35. doi: 10.1007/978-1-60327-323-7_30.

15.

The contribution of MOR-1 exons 1-4 to morphine and heroin analgesia and dependence.

Klein G, Rossi GC, Waxman AR, Arout C, Juni A, Inturrisi CE, Kest B.

Neurosci Lett. 2009 Jul 3;457(3):115-9. doi: 10.1016/j.neulet.2009.04.012. Epub 2009 Apr 9.

PMID:
19429175
16.

Involvement of exon 11-associated variants of the mu opioid receptor MOR-1 in heroin, but not morphine, actions.

Pan YX, Xu J, Xu M, Rossi GC, Matulonis JE, Pasternak GW.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4917-22. doi: 10.1073/pnas.0811586106. Epub 2009 Mar 9.

17.

Expansion of the human mu-opioid receptor gene architecture: novel functional variants.

Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L.

Hum Mol Genet. 2009 Mar 15;18(6):1037-51. doi: 10.1093/hmg/ddn439. Epub 2008 Dec 22.

18.

Identification of endomorphin-1 and endomorphin-2 binding sites in human mu-opioid receptor by antisense oligonucleotide strategy.

Fichna J, Gach K, Perlikowska R, Poels J, Vanden Broeck J, Szemraj J, Janecka A.

Chem Biol Drug Des. 2008 Dec;72(6):507-12. doi: 10.1111/j.1747-0285.2008.00725.x.

PMID:
19090917
19.

Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene.

Xu J, Xu M, Hurd YL, Pasternak GW, Pan YX.

J Neurochem. 2009 Feb;108(4):962-72. doi: 10.1111/j.1471-4159.2008.05833.x. Epub 2008 Dec 10.

20.

CB(2) cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: role of CB(2) receptor in pain.

Páldy E, Bereczki E, Sántha M, Wenger T, Borsodi A, Zimmer A, Benyhe S.

Neurochem Int. 2008 Dec;53(6-8):309-16. doi: 10.1016/j.neuint.2008.08.005. Epub 2008 Aug 29.

PMID:
18804501
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk